MONTINA L TABLET 10'S

Montina L Tablet 10's is a combination medicine used to treat allergy symptoms such as runny nose, sneezing, watery eyes, and nasal congestion.

Montina L Tablet 10's contains Montelukast and Levocetirizine.

Take Montina L Tablet 10's in the dose and duration as advised by the doctor. It can be taken with or without food, but it is better to take it at a fixed time every day.

Common side effects of Montina L Tablet 10's include nausea, vomiting, diarrhea, dry mouth, fatigue, headache, and drowsiness.

Montina L Tablet 10's can be taken with or without food.

Store Montina L Tablet 10's at room temperature, away from direct sunlight and heat.

Consult a doctor before giving Montina L Tablet 10's to children.

Consult a doctor before using Montina L Tablet 10's during pregnancy.

Consult a doctor before using Montina L Tablet 10's during breastfeeding.

Taking Montina L Tablet 10's with alcohol may increase drowsiness.

If you miss a dose of Montina L Tablet 10's, take it as soon as possible. If it is almost time for your next dose, skip the missed dose and continue with your regular schedule.

Yes, Montina L Tablet 10's can cause drowsiness.

No, Montina L Tablet 10's is not a steroid.

Consult your doctor before taking Montina L Tablet 10's with other medications, as it may cause drug interactions.

Montina L Tablet 10's usually takes about one hour to start working.

Montina L tablet is mainly used to treat allergic rhinitis (sneezing, runny or blocked nose, itching, watery eyes) and chronic urticaria (hives and itching). It may also be prescribed as an add‑on therapy in patients with allergy‑related mild asthma, but it is not a rescue medicine for sudden asthma attacks.

Montina L tablet usually combines montelukast, which blocks leukotrienes, and an antihistamine such as levocetirizine, which blocks histamine. Both leukotrienes and histamine are chemicals released during an allergic reaction. By blocking their action, the tablet helps reduce inflammation, itching, sneezing, nasal congestion, and other allergy symptoms.

No, Montina L tablet is not suitable for the immediate relief of acute asthma attacks or sudden breathing difficulty. It may be used as a preventive or add‑on therapy in allergy‑related asthma as advised by your doctor, but you must keep a separate, fast‑acting inhaler or rescue medicine for acute attacks as prescribed.

Safety of Montina L tablet in pregnancy depends on the individual components and the stage of pregnancy. Limited human data are available, and it should only be used if the potential benefit justifies the potential risk to the unborn baby. Pregnant women or those planning pregnancy must consult a doctor before starting or continuing this medicine and should never self‑medicate.

Some components of Montina L tablet may pass into breast milk in small amounts. The decision to use it during breastfeeding should be made by a doctor after weighing the benefits for the mother against potential risks to the infant. If prescribed, the baby should be monitored for unusual sleepiness, irritability, or feeding difficulties, and any concerns should be reported promptly.

Montina L tablet should be used with caution in patients with liver disease, as montelukast and some antihistamines are metabolized in the liver. Dose adjustment or close monitoring may be required, depending on the severity of liver impairment. Patients with a history of hepatitis, jaundice, or abnormal liver tests must inform their doctor before using this medicine and should report symptoms like yellowing of the skin or eyes, dark urine, or persistent fatigue.

In people with kidney impairment, especially moderate to severe kidney disease, the antihistamine component of Montina L tablet may accumulate and increase the risk of side effects such as excessive drowsiness. Your doctor may decide to adjust the dose, change the dosing interval, or choose an alternative medicine. Patients with kidney problems should not take this tablet without medical supervision.

Montina L tablet can cause drowsiness, dizziness, or reduced alertness in some individuals due to its antihistamine component. Until you know how the medicine affects you, avoid driving, operating heavy machinery, or performing tasks that require full concentration. If you feel sleepy, light‑headed, or less alert after taking it, do not drive and speak to your doctor about adjusting therapy.

Alcohol can increase the sedative effects of the antihistamine in Montina L tablet, leading to more pronounced drowsiness, dizziness, and impaired judgment. It is generally advisable to avoid or strictly limit alcohol consumption while on this medicine. If you accidentally consume alcohol, be cautious with activities like driving and inform your doctor if you experience excessive sedation or other unusual symptoms.

If you have a history of drug allergies, inform your doctor before starting Montina L tablet. Provide details of previous reactions, such as rash, swelling of the face or throat, breathing difficulty, or severe skin reactions. Do not take this medicine if you are known to be allergic to montelukast, levocetirizine, or any other ingredient in the tablet. If you develop symptoms like rash, itching, swelling, or trouble breathing after taking it, stop the medicine and seek immediate medical help.

Use of Montina L tablet in children depends on age, body weight, and the specific formulation and strengths available. Pediatric dosing must be determined only by a pediatrician or qualified healthcare professional. Parents should never give this medicine to children without a prescription, and they must follow the doctor’s instructions carefully, including duration of use and monitoring for side effects.

If you miss a dose of Montina L tablet, take it as soon as you remember, unless it is almost time for your next scheduled dose. In that case, skip the missed dose and continue with your regular schedule. Do not take a double dose to make up for the missed one. If you frequently forget doses, discuss with your doctor or pharmacist about strategies to improve adherence.